Treatment groups

Disease stages

Mean

(Pg/ml)

Std. Dev

N

Mean diff ± S.E

p-value

Pretreatment

ESBC

56.31

29.57

28

17.17 ± 14.22

0.230

ASBC

73.40

76.36

40

ESBC

56.31

29.57

28

10.40 ± 18.08

0.566

AHMC

45.91

25.74

21

ESBC

56.31

29.57

28

24.13 ± 16.24

0.140

BBT

80.44

61.03

21

ASBC

73.40

76.36

40

27.57 ± 17.07

0.109

AHMC

45.91

25.74

21

ASBC

73.40

76.36

40

6.96 ± 15.10

0.646

BBT

80.44

61.03

21

BBT

80.44

61.03

21

34.54 ± 18.78

0.069

AHMC

45.91

25.74

21

3 months Post-treatment

ESBC

77.48

61.32

28

1.94 ± 18.82

0.918

ASBC

75.54

110.88

38

ESBC

77.48

61.32

28

31.57 ± 23.93

0.190

AHMC

45.91

25.74

21

ESBC

77.48

61.32

28

33.64 ± 21.76

0.125

BBT

43.83

13.60

20

ASBC

75.54

110.88

38

29.63 ± 22.59

0.193

AHMC

45.91

25.74

21

ASBC

75.54

110.88

38

31.70 ± 20.27

0.121

BBT

43.83

13.60

20

BBT

43.83

13.60

20

2.07 ± 25.09

0.934

AHMC

45.91

25.74

21

6 months

Post-treatment

ESBC

59.00

39.77

26

33.37 ± 14.37

0.023

ASBC

95.58

72.77

31

ESBC

59.00

39.77

26

13.09 ± 17.73

0.463

AHMC

45.91

25.74

21

ESBC

59.00

39.77

26

BBT

-

-

-

ASBC

95.58

72.77

31

46.47 ± 16.77

0.007

AHMC

45.91

25.74

21

ASBC

95.58

72.77

31

BBT

-

-

-

BBT

-

-

-

AHMC

45.91

25.74

21